Guillain-Barre syndrome (GBS) is a rare autoimmune disease that often
manifests as a post-viral complication. However, its association with
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is unclear.
We present a rare case of GBS secondary to COVID-19 infection
complicated by rapidly progressive sensorimotor deterioration resistant
to plasma exchange therapy.